Kaposi's sarcoma
Kaposi's sarcoma, multiple haemorrhagic sarcoma | |
---|---|
Other names | Kaposi sarcoma |
biologic therapy[4] | |
Frequency | 42,000 (new cases, 2018)[7] |
Deaths | 20,000 (2018)[7] |
Kaposi's sarcoma (KS) is a type of
Classic, endemic, immunosuppression therapy-related (also known as iatrogenic), and epidemic (also known as AIDS-related) sub-types are all described.
Treatment is based on the sub-type, whether the condition is localized or widespread, and the person's immune function.
The condition is relatively common in people with HIV/AIDS and following organ transplant.
Signs and symptoms
KS lesions are nodules or blotches that may be red, purple, brown, or black, and are usually papular.[citation needed]
They are typically found on the skin, but spread elsewhere is common, especially the mouth,
The lesions are painless, but become cosmetically disfiguring or interruptive to organs.[15]
Skin
Commonly affected areas include the
Mouth
The mouth is involved in about 30% of cases, and is the initial site in 15% of AIDS-related KS. In the mouth, the hard palate is most frequently affected, followed by the gums.[19] Lesions in the mouth may be easily damaged by chewing and bleed or develop secondary infection, and even interfere with eating or speaking.[citation needed]
Gastrointestinal tract
Involvement can be common in those with transplant-related or AIDS-related KS, and it may occur in the absence of skin involvement. The gastrointestinal lesions may be silent or cause weight loss, pain, nausea/vomiting,
Respiratory tract
Involvement of the airway can present with shortness of breath,
Cause
Transmission
In Europe and North America, KSHV is transmitted through saliva. Thus, kissing is a risk factor for transmission. Higher rates of transmission among gay and bisexual men have been attributed to "deep kissing" sexual partners with KSHV.[24] Another alternative theory suggests that use of saliva as a sexual lubricant might be a major mode for transmission. Prudent advice is to use commercial lubricants when needed and avoid deep kissing with partners with KSHV infection or whose status is unknown.[citation needed]
KSHV is also transmissible via organ transplantation[25] and blood transfusion.[26] Testing for the virus before these procedures is likely to effectively limit iatrogenic transmission.[citation needed]
Pathology
Despite its name, in general it is not considered a true
KS lesions contain tumor cells with a characteristic abnormal elongated shape, called spindle cells. The most typical feature of Kaposi sarcoma is the presence of spindle cells forming slits containing red blood cells. Mitotic activity is only moderate and pleomorphism is usually absent.[31] The tumor is highly vascular, containing abnormally dense and irregular blood vessels, which leak red blood cells into the surrounding tissue and give the tumor its dark color. Inflammation around the tumor may produce swelling and pain. Variously sized PAS positive hyaline bodies are often seen in the cytoplasm or sometimes extracellularly.[citation needed]
The spindle cells of Kaposi sarcoma differentiate toward
-
Micrograph of promontory sign in Kaposi's sarcoma in patch stage. Dilated irregular vascular channels surround a pre-existing vessel.[16]
-
Micrograph of plaque stage, with bizarre vessels dissecting the upper dermis. There is erythrocyte extravasation and hemosiderin pigmentation.[16]
-
Micrograph of tumor stage. Well-circumscribed spindle-cell tumor. Erythrocytes lie within poorly defined slit-like vascular spaces.[16]
Diagnosis
Although KS may be suspected from the appearance of lesions and the patient's risk factors, a definite diagnosis can be made only by biopsy and microscopic examination. Detection of the KSHV protein LANA in tumor cells confirms the diagnosis.[citation needed]
In differential diagnosis, arteriovenous malformations, pyogenic granuloma and other vascular proliferations can be microscopically confused with KS.[33]
Differential diagnosis of Kaposi's sarcoma
Source:[34]
- Naevus
- Histiocytoma
- Cryptococcosis
- Histoplasmosis
- Leishmaniasis
- Pneumocystis lesions
- Dermatophytosis
- Angioma
- Bacillary angiomatosis
- Pyogenic granuloma
- Melanoma
Classification
HHV-8 is responsible for all varieties of KS. Since
- Classic Kaposi sarcoma most commonly appears early on the toes and soles as reddish, violaceous, or bluish-black macules and patches that spread and coalesce to form nodules or plaques.
- Endemic KS, which has two types. Although this may be present worldwide, it has been originally described later in young HIV infection[39][40] and is a more aggressive disease that infiltrates the skin extensively.[39][41]
- African lymphadenopathic Kaposi sarcoma is aggressive, occurring in children under 10 years of age, presenting with lymph node involvement, with or without skin lesions.[35]: 599
- African cutaneous Kaposi sarcoma presents with nodular, infiltrative, vascular masses on the extremities, mostly in men between the ages of 20 and 50, and is endemic in tropical Africa.[35]: 599
- Immunosuppression-associated Kaposi sarcoma had been described, but only rarely until the advent of transplant patients in the 1980s, when its incidence grew rapidly. The tumor arises either when an HHV 8-infected organ is transplanted into someone who has not been exposed to the virus or when the transplant recipient already harbors pre-existing HHV 8 infection.[42][43] Unlike classic Kaposi sarcoma, the site of presentation is more variable.[35]: 600
- AIDS-associated Kaposi sarcoma typically presents with cutaneous
Prevention
Blood tests to detect antibodies against KSHV have been developed and can be used to determine whether a person is at risk for transmitting the infection to their sexual partner, or whether an organ is infected before transplantation. However, these tests are not available except as research tools, and, thus, there is little screening for persons at risk for becoming infected with KSHV, such as people following a transplant.[citation needed]
Treatment
Kaposi sarcoma is not curable, but it can often be treatable for many years. In KS associated with immunodeficiency or immunosuppression, treating the cause of the immune system dysfunction can slow or stop the progression of KS. In 40% or more of patients with AIDS-associated Kaposi sarcoma, the Kaposi lesions will shrink upon first starting highly active antiretroviral therapy (HAART). Therefore, HAART is considered the cornerstone of therapy in AIDS-associated Kaposi sarcoma. However, in a certain percentage[vague] of such people, Kaposi sarcoma may recur after many years on HAART, especially if HIV is not completely suppressed.
People with a few local lesions can often be treated with local measures such as radiation therapy or
Alitretinoin, applied to the lesion, may be used when the lesion is not getting better with standard treatment of HIV/AIDS and chemotherapy or radiation therapy cannot be used.[55]
Epidemiology
With the decrease in the death rate among people with HIV/AIDS receiving new treatments in the 1990s, the rates and severity of epidemic KS also decreased. However, the number of people living with HIV/AIDS is increasing in the United States, and it is possible that the number of people with AIDS-associated Kaposi sarcoma will again rise as these people live longer with HIV infection.[citation needed]
Society
This section needs additional citations for verification. (November 2020) |
Because of their highly visible nature, external lesions are sometimes the presenting symptom of AIDS. Kaposi sarcoma entered the awareness of the general public with the release of the film Philadelphia, in which the main character was fired after his employers found out he was HIV-positive due to visible lesions. By the time KS lesions appear, likely, the immune system has already been severely weakened.[citation needed] It has been reported that only 6% of men who have sex with men are aware that KS is caused by a virus different from HIV.[56] Thus, there is little community effort to prevent KSHV infection. Likewise, no systematic screening of organ donations is in place.
In people with AIDS, Kaposi sarcoma is considered an opportunistic infection, a disease that can gain a foothold in the body because the immune system has been weakened. With the rise of HIV/AIDS in Africa, where KSHV is widespread, KS has become the most frequently reported cancer in some countries.
References
- PMID 20525327.
- ^ Collins English Dictionary – Complete and Unabridged, 12th Edition 2014. S.v. "Kaposi's sarcoma." Retrieved August 15, 2017 from http://www.thefreedictionary.com/Kaposi's+sarcoma
- ^ Random House Kernerman Webster's College Dictionary. S.v. "Kaposi's sarcoma." Retrieved August 15, 2017 from http://www.thefreedictionary.com/Kaposi's+sarcoma
- ^ a b c d e f g h "Kaposi Sarcoma Treatment". National Cancer Institute. 16 June 2017.
- PMID 28324233.
- ^ PMID 18638627.
- ^ a b The Global Cancer Observatory (2019). "Kaposi sarcoma" (PDF). Retrieved 14 March 2020.
- ^ PMID 30705286.
- ^ S2CID 9700628.
- ISBN 9780323529570.
- ^ a b c "Kaposi Sarcoma Treatment". National Cancer Institute. 1 October 2015. Retrieved 18 December 2017.
- S2CID 31438763.
- S2CID 29977325.
- PMID 8880194.
- ^ Kaposi's Sarcoma. Vol. 21. F. A. Davis Company. 2009. p. 1256.
{{cite encyclopedia}}
:|work=
ignored (help) - ^ PMID 21533260.
- PMID 3603057.
- ISBN 978-3-319-46352-0.
- PMID 8227776. Archived from the originalon 2007-09-29. Retrieved 2007-06-11.
- PMID 2038993.
- S2CID 41623543.
- PMID 12097251.
- PMID 18948197.
- PMID 11070101.
- PMID 9326251.
- PMID 17005950.
- ISBN 978-0-87969-571-2.
- PMID 9973245.
- PMID 23936513.
- PMID 2986460.
- ISBN 978-0-8089-2433-3.
- PMID 10068212.
- PMID 2983633.
- ISBN 9781118441190.
- ^ ISBN 978-0-7216-2921-6..
- PMID 21546753.
- S2CID 23848900.
- PMID 9781608.
- ^ PMID 9836488.
- S2CID 1734745.
- S2CID 1734745.
- PMID 9500639.
- PMID 11070102.
- PMID 7332494.
- Hausen HZ(2006). "Rhadinoviruses". Infections Causing Human Cancer. Weinheim: Wiley-VCH.
- ^ Drabell FG (2006). "Kaposi's Sarcoma and Renal Diseases". New Topics in Cancer Research. New York: Nova Biomedical Books.
- S2CID 35639169.
- S2CID 19909703.
- PMID 23316984.
- PMID 24464843.
- PMID 26269192.
- PMID 27986137.
- PMID 10561228.
- PMID 10861090.
- ^ "Summary of Product Characteristics" (PDF). EMA. Retrieved 14 March 2020.
- PMID 18665016.
External links
- Kaposi sarcoma photo library at Dermnet Archived 2010-11-08 at the Wayback Machine